FOSAPREPITANT EQUITY


LYOPHILISED POWDER FOR SOLUTION FOR INFUSION
scheduling status
S4
registration number
56/5.7.2/1178
What FOSAPREPITANT EQUITY contains
Each vial of Fosaprepitant Equity lyophilised powder for solution for infusion contains 245,3 mg of fosaprepitant dimeglumine equivalent to 150 mg of fosaprepitant free acid. Contains sugar (anhydrous lactose) 375 mg per vial.
other ingredients
Anhydrous lactose Edetate disodium Hydrochloric acid (for pH adjustment) Polysorbate 80 Sodium hydroxide (for pH adjustment) Water for Injection.
Therapeutic classification
A04AD12.
© 2026 SAHPRA. ALL RIGHTS RESERVED